{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA078314"
        ],
        "brand_name": [
          "NAPROXEN SODIUM"
        ],
        "generic_name": [
          "NAPROXEN SODIUM"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-178",
          "68462-188",
          "68462-189",
          "68462-190",
          "68462-179"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "NAPROXEN SODIUM"
        ],
        "rxcui": [
          "198012",
          "198013",
          "198014",
          "849398",
          "849431"
        ],
        "spl_id": [
          "16372549-a419-4920-a200-5128017570ed"
        ],
        "spl_set_id": [
          "6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"
        ],
        "package_ndc": [
          "68462-188-01",
          "68462-188-05",
          "68462-189-01",
          "68462-189-05",
          "68462-190-30",
          "68462-190-50",
          "68462-190-01",
          "68462-190-05",
          "68462-178-01",
          "68462-178-05",
          "68462-179-01",
          "68462-179-05"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462189016",
          "0368462178010",
          "0368462179017",
          "0368462188019",
          "0368462190012"
        ],
        "nui": [
          "N0000000160",
          "M0001335",
          "N0000175722"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]"
        ],
        "unii": [
          "9TN87S3A3C",
          "57Y76R9ATQ"
        ]
      },
      "product_type": "Drugs",
      "event_id": "88591",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-0821-2021",
      "product_description": "Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430",
      "product_quantity": "9552 bottles",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20210827",
      "center_classification_date": "20210921",
      "termination_date": "20231004",
      "report_date": "20210929",
      "code_info": "Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022",
      "more_code_info": ""
    }
  ]
}